Bruno Battistini

Summary

Country: Canada

Publications

  1. ncbi The many aspects of endothelins in ischemia-reperfusion injury: emergence of a key mediator
    B Battistini
    Heart and Lung Institute, Laval Hospital, Laval University, Ste Foy, Quebec, Canada
    J Invest Surg 11:297-313. 1998
  2. ncbi Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, 2725 Chemin Ste Foy, Sainte Foy, QC G1V 4G5, Canada
    Can J Physiol Pharmacol 81:555-69. 2003
  3. ncbi Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model
    B Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste Foy, QC, Canada
    J Cardiovasc Pharmacol 44:S386-9. 2004
  4. ncbi Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, 2725 Chemin Ste Foy, Ste Foy, QC, Canada G1V 4G5
    Clin Sci (Lond) 103:363S-366S. 2002
  5. ncbi CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste Foy, QC G1V 4G5, Canada
    Cardiovasc Drug Rev 23:317-30. 2005
  6. ncbi Roles of endothelins and their receptors in immune complex-induced/polymorphonuclear-mediated lung injury (reversed passive arthus reaction) in CD-1 mice
    B Battistini
    Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada
    Pulm Pharmacol Ther 11:165-72. 1998
  7. ncbi Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Sainte Foy, Canada
    Exp Biol Med (Maywood) 231:653-95. 2006
  8. ncbi Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats
    Philippe Daull
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste-Foy, QC, Canada
    Am J Hypertens 18:1606-13. 2005
  9. ncbi Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats
    Philippe Daull
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Laval University, Quebec, QC, Canada
    J Cardiovasc Pharmacol 44:S398-401. 2004
  10. ncbi Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism
    Bilal Ayach
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, 2725 Chemin Ste-Foy, Ste-Foy, QC G1V 4G5, Canada
    Clin Sci (Lond) 103:371S-375S. 2002

Collaborators

Detail Information

Publications28

  1. ncbi The many aspects of endothelins in ischemia-reperfusion injury: emergence of a key mediator
    B Battistini
    Heart and Lung Institute, Laval Hospital, Laval University, Ste Foy, Quebec, Canada
    J Invest Surg 11:297-313. 1998
    ..Here we review the evidence supporting a role for ETs in the various etiologies related to ischemia-reperfusion injury, such as is found in heart disease, cerebral ischemia, and organ transplantation...
  2. ncbi Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, 2725 Chemin Ste Foy, Sainte Foy, QC G1V 4G5, Canada
    Can J Physiol Pharmacol 81:555-69. 2003
    ..Thus, we may consider ET inhibitors as future current therapeutic agents in patients with PE...
  3. ncbi Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model
    B Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste Foy, QC, Canada
    J Cardiovasc Pharmacol 44:S386-9. 2004
    ..However, modulation of the central hemodynamic profile is more complex and may limit the usefulness of some ET blockers...
  4. ncbi Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, 2725 Chemin Ste Foy, Ste Foy, QC, Canada G1V 4G5
    Clin Sci (Lond) 103:363S-366S. 2002
    ....
  5. ncbi CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste Foy, QC G1V 4G5, Canada
    Cardiovasc Drug Rev 23:317-30. 2005
    ..Similar in vivo ACE, NEP, and ECE inhibitory activities were also observed with the orally active prodrug, CGS 37808 (L-tryptophan, N-[[1-[[(2S)-2-(acetylthio)-4-methyl-1-oxopentyl]amino]cyclopentyl]-carbonyl]-, methyl ester...
  6. ncbi Roles of endothelins and their receptors in immune complex-induced/polymorphonuclear-mediated lung injury (reversed passive arthus reaction) in CD-1 mice
    B Battistini
    Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada
    Pulm Pharmacol Ther 11:165-72. 1998
    ..A beneficial ETB-mediated response may exist that naturally interferes with events triggered by the formation of immune complexes such as cell accumulation and their subsequent activation leading to acute lung injury...
  7. ncbi Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Sainte Foy, Canada
    Exp Biol Med (Maywood) 231:653-95. 2006
    ..This review is intended to provide a useful reference for those interested in the current state of clinical trials involving ERAs, and to identify lessons that might apply to the design of future trials...
  8. ncbi Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats
    Philippe Daull
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste-Foy, QC, Canada
    Am J Hypertens 18:1606-13. 2005
    ..Only then it may constitute a first-in-class approach for the treatment of hypertension and other cardiovascular disorders...
  9. ncbi Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats
    Philippe Daull
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Laval University, Quebec, QC, Canada
    J Cardiovasc Pharmacol 44:S398-401. 2004
    ..Additional studies are underway...
  10. ncbi Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism
    Bilal Ayach
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, 2725 Chemin Ste-Foy, Ste-Foy, QC G1V 4G5, Canada
    Clin Sci (Lond) 103:371S-375S. 2002
    ..These results show that ET(A)-R subtype is involved in the pathogenesis of APAE since a blockade of this receptor subtype attenuated the cardiopulmonary deterioration and improved blood gas exchanges in rats with this disease...
  11. ncbi The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy
    Bichoy H Gabra
    IPS Pharma Inc, Sherbrooke J1H 5N4, QC, Canada
    Biol Chem 387:127-43. 2006
    ..Thus, selective antagonism of the inducible BKB1-R subtype may constitute a novel and potential therapeutic approach for the treatment of painful diabetic neuropathy...
  12. ncbi Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist
    Bichoy H Gabra
    Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Canada
    J Neuropathol Exp Neurol 64:782-9. 2005
    ..Thus, selective antagonism of the inducible BKB1-R subtype may constitute a novel and potential therapeutic approach for the treatment of PDN...
  13. ncbi Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases
    Philippe Daull
    Millenia Hope Inc, Kirkland, Quebec, Canada
    J Cardiovasc Pharmacol 50:247-56. 2007
    ..In this review, we historically present the advances made in the comprehension of the different mechanisms of blood pressure regulation and some of the drugs that arose from this understanding...
  14. ncbi Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs
    Sibi R Lawson
    Institute of Pharmacology of Sherbrooke (IPS, School of Medicine, University of Sherbrooke, Sherbrooke, Province of Quebec, Canada J1H 5N4
    Eur J Pharmacol 514:69-78. 2005
    ....
  15. ncbi Profile of endothelin isopeptides and markers of oxidative stress alongside the onset of streptozotocin-type I diabetes in rats
    Ouhida Benrezzak
    IPS Pharma Inc, Sherbrooke, QC, Canada
    J Cardiovasc Pharmacol 44:S168-72. 2004
    ....
  16. ncbi Inhibition of endothelin-converting enzyme for protection against neointimal proliferation following balloon angioplasty of the rat carotid artery
    Dung Pham
    Laval Hospital Research Center, Department of Medicine, Laval University, Sainte-Foy, QC, Canada
    Can J Physiol Pharmacol 80:450-7. 2002
    ..Plasma concentrations of these compounds correlated with the degree of inhibition. These data support the participation of the endothelin system in the rat model of balloon angioplasty and suggest that selective ECEi may be effective...
  17. ncbi Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers
    Quan Yang
    Institute of Pharmacology of Sherbrooke, Medical School, University of Sherbrooke, Sherbrooke, QC, J1H 5N4, Canada
    Inflammation 30:136-47. 2007
    ....
  18. ncbi Early endothelial dysfunction in cholesterol-fed rabbits: a non-invasive in vivo ultrasound study
    Marie Claude Drolet
    Groupe de Recherche en Valvulopathies, Institut de Cardiologie de Quebec, Centre de recherche Hopital Laval, Universite Laval, 2725 Chemin Sainte Foy, Sainte Foy, Canada
    Cardiovasc Ultrasound 2:10. 2004
    ..Endothelial function in hypercholesterolemic rabbits is usually evaluated ex vivo on isolated aortic rings. In vivo evaluation requires invasive imaging procedures that cannot be repeated serially...
  19. ncbi Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs
    John Tsang
    Department of Medicine, University of British Columbia, Vancouver, Canada
    J Invest Surg 15:29-35. 2002
    ..We conclude that these cytokines have minimal impact on the systemic circulation during APTE...
  20. ncbi Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications
    Arco Y Jeng
    Metabolic and Cardiovascular Diseases Research, Novartis Institute for Biomedical Research, Summit, NJ 07901, USA
    Can J Physiol Pharmacol 80:440-9. 2002
    ..Potential clinical applications of these compounds in hypertension, chronic heart failure, restenosis, renal failure, and cerebral vasospasm deduced from studies with relevant animal models are reviewed...
  21. ncbi Classification of endothelin receptors and antagonists in clinical development
    Anthony P Davenport
    Clinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K
    Clin Sci (Lond) 103:1S-3S. 2002
  22. ncbi The endothelin axis: emerging role in cancer
    Joel Nelson
    University of Pittsburgh School of Medicine, 5200 Centre Avenue, Pittsburgh, PA 15232, USA
    Nat Rev Cancer 3:110-6. 2003
    ..The place of ET-receptor antagonists in cancer therapy for a range of malignancies merits further investigation...
  23. ncbi Plasma levels of endothelin-1, big endothelin-1 and thromboxane following acute pulmonary air embolism
    Mathieu Simon
    Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada V6Z 1Y6
    Respir Physiol Neurobiol 138:97-106. 2003
    ..These results showed that during APAE, the resulted changes in the pulmonary vascular and airway tones mediated by these potent mediators could explain the observed pulmonary hypertension and the deterioration of gas exchange...
  24. ncbi Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines
    Martin Coulombe
    Centre de Recherche, , Institut Universitaire de Cardiologie et de Pneumologie, , 2725 Chemin Sainte-Foy, Sainte-Foy, , Canada G1V 4G5
    J Leukoc Biol 71:829-36. 2002
    ..Thus, our data suggest that ETs may play an important role in modulating the cytokine network by regulating Th1/Th2 cytokine production by mast cells...
  25. ncbi Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats
    Farzad Moien-Afshari
    Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
    Maturitas 45:213-23. 2003
    ..Apoptosis of endothelial cells is greatest in arteries from male rats. Our data suggests that early ERT treatment may be an important consideration for reducing endothelium-dependent vascular dysfunction...